SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-039183
Filing Date
2023-11-02
Accepted
2023-11-02 17:29:24
Documents
13
Period of Report
2023-11-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 60204
2 ex10-1.htm EX-10.1 181041
  Complete submission text file 0001493152-23-039183.txt   458019

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE envb-20231102.xsd EX-101.SCH 3012
4 XBRL LABEL FILE envb-20231102_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE envb-20231102_pre.xml EX-101.PRE 22357
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3443
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 231373756
SIC: 2834 Pharmaceutical Preparations